This week’s articles reveal a new treatment for malaria and an adjunct therapy that may reduce the hematologic toxicity of chemotherapy.
MALARIA
A new antimalarial
Paquet et al. discover that an inhibitor of phosphatidylinositol 4-kinase may treat and prevent malaria.
CANCER
Rock-a-bye stem cells
He et al. show that inhibiting the kinases CDK4 and CDK6 may prevent chemotherapy-induced bone marrow toxicity and immunosuppression in cancer patients.